Literature DB >> 27822731

Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas.

Hasan Nazik1,2,3, Richard B Moss4, Vyshnavi Karna1, Karl V Clemons1,2, Niaz Banaei2,5, Kevin Cohen1, Varun Choudhary1, David A Stevens6,7.   

Abstract

Pseudomonas aeruginosa and Aspergillus fumigatus are the leading bacterial and fungal pathogens in cystic fibrosis (CF). We have shown that Af biofilms are susceptible to Pseudomonas, particularly CF phenotypes. Those studies were performed with a reference virulent non-CF Aspergillus. Pseudomonas resident in CF airways undergo profound genetic and phenotypic adaptations to the abnormal environment. Studies have also indicated Aspergillus from CF patients have unexpected profiles of antifungal susceptibility. This would suggest that Aspergillus isolates from CF patients may be different or altered from other clinical isolates. It is important to know whether Aspergillus may also be altered, as a result of that CF environment, in susceptibility to Pseudomonas. CF Aspergillus proved not different in that susceptibility.

Entities:  

Keywords:  Aspergillus; Biofilm; Cystic fibrosis; Intermicrobial interaction; Pseudomonas

Mesh:

Substances:

Year:  2016        PMID: 27822731     DOI: 10.1007/s11046-016-0087-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  10 in total

1.  High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.

Authors:  Pierre-Régis Burgel; Marie-Thérèse Baixench; Michaël Amsellem; Etienne Audureau; Jeanne Chapron; Reem Kanaan; Isabelle Honoré; Jean Dupouy-Camet; Daniel Dusser; Corné H Klaassen; Jacques F Meis; Dominique Hubert; André Paugam
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  Molecular epidemiology of Aspergillus collected from cystic fibrosis patients.

Authors:  Raquel Sabino; Jose A G Ferreira; Richard B Moss; Joana Valente; Cristina Veríssimo; Elisabete Carolino; Karl V Clemons; Cassie Everson; Niaz Banaei; John Penner; David A Stevens
Journal:  J Cyst Fibros       Date:  2014-10-30       Impact factor: 5.482

3.  Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.

Authors:  Klaus Leth Mortensen; Rasmus Hare Jensen; Helle Krogh Johansen; Marianne Skov; Tacjana Pressler; Susan Julie Howard; Howard Leatherbarrow; Emilia Mellado; Maiken Cavling Arendrup
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

4.  Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.

Authors:  D W Denning; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

5.  Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm.

Authors:  Hasan Nazik; John C Penner; Jose A Ferreira; Janus A J Haagensen; Kevin Cohen; Alfred M Spormann; Marife Martinez; Vicky Chen; Joe L Hsu; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

6.  Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center.

Authors:  David A Stevens; Richard B Moss; Cathy Hernandez; Karl V Clemons; Marife Martinez
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

7.  Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin.

Authors:  D W Denning; K V Clemons; L H Hanson; D A Stevens
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

8.  High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.

Authors:  Florent Morio; Guillaume G Aubin; Isabelle Danner-Boucher; Alain Haloun; Emilie Sacchetto; Dea Garcia-Hermoso; Stéphane Bretagne; Michel Miegeville; Patrice Le Pape
Journal:  J Antimicrob Chemother       Date:  2012-05-11       Impact factor: 5.790

9.  High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.

Authors:  David W Denning; Steven Park; Cornelia Lass-Florl; Marcin G Fraczek; Marie Kirwan; Robin Gore; Jaclyn Smith; Ahmed Bueid; Caroline B Moore; Paul Bowyer; David S Perlin
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

10.  Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium.

Authors:  Jose A G Ferreira; John C Penner; Richard B Moss; Janus A J Haagensen; Karl V Clemons; Alfred M Spormann; Hasan Nazik; Kevin Cohen; Niaz Banaei; Elisabete Carolino; David A Stevens
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  10 in total
  7 in total

1.  Small Colony Variants of Pseudomonas aeruginosa Display Heterogeneity in Inhibiting Aspergillus fumigatus Biofilm.

Authors:  Rajesh Anand; Richard B Moss; Gabriele Sass; Niaz Banaei; Karl V Clemons; Marife Martinez; David A Stevens
Journal:  Mycopathologia       Date:  2017-08-07       Impact factor: 2.574

Review 2.  Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis.

Authors:  Efthymia I Matthaiou; Gabriele Sass; David A Stevens; Joe L Hsu
Journal:  Curr Opin Infect Dis       Date:  2018-12       Impact factor: 4.915

3.  Studies of Pseudomonas aeruginosa Mutants Indicate Pyoverdine as the Central Factor in Inhibition of Aspergillus fumigatus Biofilm.

Authors:  Gabriele Sass; Hasan Nazik; John Penner; Hemi Shah; Shajia Rahman Ansari; Karl V Clemons; Marie-Christine Groleau; Anna-Maria Dietl; Paolo Visca; Hubertus Haas; Eric Déziel; David A Stevens
Journal:  J Bacteriol       Date:  2017-12-05       Impact factor: 3.490

4.  Interactions of Aspergillus fumigatus and Stenotrophomonas maltophilia in an in vitro Mixed Biofilm Model: Does the Strain Matter?

Authors:  Elise Melloul; Lolita Roisin; Marie-Fleur Durieux; Paul-Louis Woerther; Delphine Jenot; Veronica Risco; Jacques Guillot; Eric Dannaoui; Jean-Winoc Decousser; Françoise Botterel
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

5.  Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis.

Authors:  Jingming Zhao; Wencheng Yu
Journal:  PeerJ       Date:  2018-11-09       Impact factor: 2.984

6.  Aspergillus Is Inhibited by Pseudomonas aeruginosa Volatiles.

Authors:  Hasan Nazik; Gabriele Sass; Eric Déziel; David A Stevens
Journal:  J Fungi (Basel)       Date:  2020-07-25

Review 7.  Crosstalk between the Intestinal Virome and Other Components of the Microbiota, and Its Effect on Intestinal Mucosal Response and Diseases.

Authors:  Njinju Asaba Clinton; Sodiq Ayobami Hameed; Eugene Kusi Agyei; Joy Chinwendu Jacob; Victor Oyewale Oyebanji; Cyril Ekabe Jabea
Journal:  J Immunol Res       Date:  2022-09-27       Impact factor: 4.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.